Physician profile
Jason Bosco
NPI 1285610865
$581.44
in general payments reported to CMS, 2019-2025
12 companies · $74.89 in 2025
The $74.89 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2021: $226 · 2023: $24.49 · 2024: $107 · 2025: $74.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $206.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $148.10 | 2021 | |
| Hologic Sales and Service, LLC | $123.10 | 2019-2025 | Acessa Provu System, Myosure Tissue Removal Device, Fluent Fluid Management System |
| Abbvie INC. | $82.95 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $39.56 | 2024 | Myfembree |
| Roche Diagnostics Corporation | $38.23 | 2019 | |
| Astellas Pharma US INC | $32.59 | 2024 | Veozah |
| Avion Pharmaceuticals | $25.61 | 2019 | |
| Exeltis, USA INC. | $24.49 | 2023 | Slynd |
| Biogen, INC. | $21.55 | 2025 | Zurzuvae |
| Amag Pharmaceuticals, INC. | $20.15 | 2019 | |
| Organon LLC | $14.22 | 2024 | |
| Pfizer INC. | $10.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Bosco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.